SEK 3.06
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 63.75 Million SEK | -22.3% |
2022 | 82.05 Million SEK | -11.38% |
2021 | 92.58 Million SEK | 95.01% |
2020 | 47.47 Million SEK | 9.51% |
2019 | 43.35 Million SEK | 304.49% |
2018 | 10.71 Million SEK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 59.45 Million SEK | -3.72% |
2024 Q1 | 61.74 Million SEK | -3.15% |
2024 Q3 | 58.76 Million SEK | -1.15% |
2023 Q3 | 71.89 Million SEK | -4.42% |
2023 FY | 63.75 Million SEK | -22.3% |
2023 Q1 | 76.14 Million SEK | -7.19% |
2023 Q4 | 63.75 Million SEK | -11.32% |
2023 Q2 | 75.21 Million SEK | -1.22% |
2022 Q3 | 77.04 Million SEK | -4.69% |
2022 FY | 82.05 Million SEK | -11.38% |
2022 Q2 | 80.83 Million SEK | -8.62% |
2022 Q1 | 88.45 Million SEK | -4.46% |
2022 Q4 | 82.05 Million SEK | 6.49% |
2021 Q1 | - SEK | -100.0% |
2021 FY | 92.58 Million SEK | 95.01% |
2021 Q4 | 92.58 Million SEK | 53.21% |
2021 Q3 | 60.43 Million SEK | 4.85% |
2021 Q2 | 57.63 Million SEK | 0.0% |
2020 FY | 47.47 Million SEK | 9.51% |
2020 Q4 | 47.47 Million SEK | -10.6% |
2020 Q3 | 53.1 Million SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2019 FY | 43.35 Million SEK | 304.49% |
2018 FY | 10.71 Million SEK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aino Health AB (publ) | 13.51 Million SEK | -371.763% |
Bonzun AB (publ) | 46.75 Million SEK | -36.366% |
Kontigo Care AB (publ) | 49.77 Million SEK | -28.097% |
RaySearch Laboratories AB (publ) | 1.95 Billion SEK | 96.735% |
Surgical Science Sweden AB (publ) | 4.7 Billion SEK | 98.644% |